HypGen Inc
Change company Symbol lookup
Select an option...
HPGN HypGen Inc
IX Orix Corp
WHR Whirlpool Corp
PG Procter & Gamble Co
PWJAX PGIM Jennison International Opportunities Fund- Class A
MBWM Mercantile Bank Corp
MEIUF Meitu Inc
HD Home Depot Inc
ACC American Campus Communities Inc
MRLN Marlin Business Services Corp
Go

Company profile

HypGen Inc., formerly Mega Bridge Inc., is a clinical-staged biotechnology company. The Company through its platform is focused on development and commercialization of Phorbol 12-myristate 13-acetate (PMA) internal i.d. RP-323, a focused immunotherapy and stem cell activator for treating neurological diseases (CNS). The Company is entering into phase II clinical study for developing treatments for neurological and Parkinson’s disease at cellular level. Parkinson’s disease is a progressive, degenerative neurological disease, resulting from degeneration of neurons in a region of the brain that controls movement.

Closing Price
--
Day's Change
--
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
0

Zacks Earnings Trends Highlights: Exxon, Chevron, Ford, Apple and JPMorgan

6:26 am ET April 1, 2021 (Zacks) Print

For Immediate Release

Chicago, IL – April 1, 2021 – Zacks Director of Research Sheraz Mian says, “Total 2021 Q1 earnings are currently expected to be up +19.9% from the same period last year on +5.6% higher revenues."

Return of Strong Earnings Growth

Note: The following is an excerpt from this week's Earnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following periods, please click here>>>

Here are the key points:

  • The overall earnings picture continues to improve, a trend that we strongly feel will accelerate as we move towards the Summer months and signs of a sharp economic rebound emerge.
  • Total 2021 Q1 earnings are currently expected to be up +19.9% from the same period last year on +5.6% higher revenues, with a combination of easy comparisons and strong gains in a number of sectors giving us the growth rebound.
  • Estimates for the current and coming quarters have steadily moved up, a trend that has been in place since last Summer. We expect this favorable revisions trend to accelerate in the coming months as we start looking past the pandemic.
  • The positive revisions trend is broad-based, with Q1 estimates for 10 of the 16 Zacks sectors going up over the last three months and estimates for the Autos and Energy sectors more than doubling over that time period.
  • Other sectors experiencing positive estimate revisions include Basic Materials, Construction, Industrial Products, Technology and Finance.
  • On the negative side, estimates have come down the most for the Transportation sector, with the Consumer Discretionary and Aerospace sectors also suffering estimate cuts.
  • The sectors with positive earnings growth in Q1 include: Finance (+45.9% earnings growth), Technology (+23.0%), Autos (+200.9%), Retail (+41.4%), Medical (+16.5%), Basic Materials (+66.4%), Construction (+36.8%), Industrial Products (+22.9%), Utilities (+3.1%), and Consumer Staples (+1.9%).
  • The weakest earnings growth in Q1 is expected to come from Transportation (-159.2% earnings decline), Consumer Discretionary (-36.3%), and Energy (-0.3%).
  • For the Finance sector, Q1 earnings are expected to be up +45.9% on +1.2% higher revenues, as the group's year-earlier results were dragged down by big loan-loss reserves at the banks as the pandemic got underway.
  • For the Technology sector, Q1 earnings are expected to be up +23.0% from the same period last year on +18.0% higher revenues, a clear case of strong growth and not easy comparisons.
  • For the 14 S&P 500 members with fiscal quarters ending in February that have reported results already, total earnings and revenues are up +14.6% and +10.5%, respectively, and they are beating EPS and revenue estimates at the rate of 85.7%. All these fiscal February-quarter companies get counted as part of our March-quarter tally.
  • Looking at the calendar-year picture for the S&P 500 index, earnings are projected to climb +24.4% on +8.4% higher revenues in 2021 and increase +14.8% on +6.3% higher revenues in 2022. This would follow a decline of -13.0% in 2020 on -1.8% lower revenues.
  • The implied 'EPS' for the S&P 500 index, calculated using current 2021 P/E of 23.4X and index close, as of March 30th, is $169.00, up from $135.80 in 2020. Using the same methodology, the index 'EPS' works out to $194.04 for 2022 (P/E of 20.4X). The multiples have been calculated using the index's total market cap and aggregate bottom-up earnings for each year.

Rising Earnings Estimates

The favorable revisions trend that has been pushing estimates higher since last July remains in place.

Estimates have gone up the most for the Energy and Autos sectors, with Q1 earnings estimates for these two sectors more than doubling over the last three months. You can see this pronounced positive revisions trend in estimates for Exxon XOM, Chevron CVX, Ford F and others from these two sectors.

Estimates have gone up across the board, with 10 of the 16 Zacks sectors experiencing positive estimate revisions. While the Energy and Auto sectors' increases have been the biggest in proportional terms, the magnitude of estimate increases are highest for the Technology and Finance sectors, a testament to these sectors' status as the biggest earnings contributors to the S&P 500 index.

You can clearly see this by looking at recent revisions trends for Apple AAPL and JPMorgan JPM that provide good representations for their respective sectors.

We expect the favorable revisions trend to gain pace as companies start reporting Q1 results in mid-April and share what they see as trends in underlying economic conditions.

We remain positive in our earnings outlook, as we see the full-year 2021 growth picture steadily improving through the first half of the year as more of the population gets vaccinated.

The flow of recent economic readings about the retail spending, housing starts, and the factory space suggest that activity levels moderated in February, likely reflecting unusual weather and the lingering effects on the pandemic. But with the extraordinary vaccination effort steadily gaining pace and new stimulus checks heading out, it is reasonable to expect the economic growth trend to turn around meaningfully in the coming days.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Follow us on Twitter:  https://www.twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
JPMorgan Chase & Co. (JPM): Free Stock Analysis Report
 
Ford Motor Company (F): Free Stock Analysis Report
 
Apple Inc. (AAPL): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.